Cargando…
A case report of bosutinib-induced interstitial granulomatous drug reaction in a patient with chronic myelogenous leukemia: a case report
Bosutinib is a BCR-ABL tyrosine kinase inhibitor approved for the treatment of Philadelphia chromosome–positive chronic myelogenous leukemia. We report a case of bosutinib-induced interstitial granulomatous drug reaction in a 50-year-old Caucasian female with chronic myelogenous leukemia. Histologic...
Autores principales: | Aria, Alexander B, Chen, Leon, Huen, Auris O |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134482/ https://www.ncbi.nlm.nih.gov/pubmed/30214807 http://dx.doi.org/10.1177/2050313X18795075 |
Ejemplares similares
-
Diagnostic challenge of aleukemic leukemia cutis preceding acute myelogenous leukemia: A case report
por: Du, Amy X, et al.
Publicado: (2020) -
A case of a delayed granulomatous reaction on the face following microneedling: A case report
por: Heck, Emma, et al.
Publicado: (2022) -
Bosutinib in the management of chronic myelogenous leukemia
por: Amsberg, Gunhild Keller-von, et al.
Publicado: (2013) -
Granulomatous and systemic inflammatory reactions from tattoo ink: Case
report and concise review
por: Bose, Reetesh, et al.
Publicado: (2020) -
Cobimetinib- and vemurafenib-induced granulomatous dermatitis and
erythema induratum: A case report
por: Iafolla, Marco AJ, et al.
Publicado: (2019)